NRichDx Revolution CTC Enrichment Kit (Epithelial Cell Origin)

NRichDx has launched the research-use-only Revolution CTC Enrichment Kit (Epithelial Cell Origin) to isolate circulating tumor cells from up to 40 ml of whole-blood samples for liquid biopsy assay research and development. The new kit specifically captures CTCs from cancers originating in epithelial cells, known as carcinomas, including cancers of the breast, lung, colon, prostate, and bladder. The kit uses immunomagnetic enrichment with antibodies to established cellular markers, including epithelial cell adhesion molecule (EpCAM), and is optimized to isolate greater numbers of CTCs and fewer non-relevant artifacts, the company said.